Background Pediatric and adult brain tumors, including glioblastoma, astrocytoma, ependymoma, and medulloblastoma, remain associated with poor prognosis despite advances in surgery, radiation, and chemotherapy. Therapeutic resistance, tumor heterogeneity, and treatment-related toxicity highlight the need for clinically...
Margarita Gutova, Eric Ma, H. Natri et al.· bioRxiv· 0 citations
A versatile and modular platform that enables programmable control of CAR T-cell activity is reported, offering a new strategy to overcome tumor heterogeneity and immune suppression.
Cheng-Fu Kuo, Zhen Tong, Yi-Chiu Kuo et al.· Cancer immunology research· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.